SCHEMBL23280774

SCHEMBL23280774

CCOC(=O)C1CN(I)CCC1=O

nearest known ligand 0.68

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.49
ALDH1A1 P00352 8/20 0.42
MEN1 O00255 3/20 0.41
KMT2A Q03164 3/20 0.41
KDM4E B2RXH2 1/20 0.41
GAA P10253 1/20 0.41
HPGD P15428 1/20 0.41
HSD17B10 Q99714 1/20 0.41
TLR4 O00206 1/20 0.38
SMN1; SMN2 Q16637 2/20 0.37
NPC1 O15118 1/20 0.36
POLB P06746 1/20 0.36
CHRM2 P08172 1/20 0.35
CHRM4 P08173 1/20 0.35
CHRM5 P08912 1/20 0.35
CHRM1 P11229 1/20 0.35
CHRM3 P20309 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19261817 0.86 TLR4 (0.46) MAPTALDH1A1MEN1KMT2AKDM4E
SCHEMBL13039144 0.84 MAPT (0.46) MAPTALDH1A1MEN1KMT2AKDM4E
SCHEMBL3286457 0.83 MAPT (0.47) MAPTALDH1A1MEN1KMT2AKDM4E
SCHEMBL20822144 0.82 BRD4 (0.41) ALDH1A1GAACHRM2CHRM4CHRM5
SCHEMBL10654584 0.81 MAPT (0.46) MAPTALDH1A1MEN1KMT2AKDM4E
SCHEMBL2782732 0.81 MAPT (0.46) MAPTALDH1A1MEN1KMT2AKDM4E
SCHEMBL10296047 0.81 MAPT (0.46) MAPTALDH1A1MEN1KMT2AKDM4E
SCHEMBL5871351 0.80 MAPT (0.44) MAPTALDH1A1MEN1KMT2AKDM4E
SCHEMBL2127522 0.80 MAPT (0.44) MAPTALDH1A1MEN1KMT2AKDM4E
SCHEMBL11568317 0.79 MAPT (0.43) MAPTALDH1A1MEN1KMT2AKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3170823-B1 6,7-DIHYDRO-2H-PYRAZOLO[4,3-C]PYRIDIN-3(5H)-ONE DERIVATIVES AND THEIR USE FOR TREATING A DISEASE ASSOCIATED WITH AMPK KINASE ACTIVITY SHANGHAI INST MATERIA MEDICA CAS (CN) 2021-04-28 EP disclosed